The Evolution of Polymeric Materials in Vision Care and Ophthalmology meddeviceonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from meddeviceonline.com Daily Mail and Mail on Sunday newspapers.
FDA Approves Bausch + Lomb ClearVisc™ Dispersive Ophthalmic Viscosurgical Device
News provided by
Share this article
New OVD Offers Exceptional Corneal Protection, Visibility During Ophthalmic Surgery
LAVAL, QC, April 7, 2021 /PRNewswire/ Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ( Bausch Health ), today announced that the U.S. Food and Drug Administration (FDA) has approved ClearVisc™ dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery. The ClearVisc™ dispersive OVD is the latest advancement in Bausch + Lomb s rich pipeline of ophthalmic surgical devices and is representative of our company s ongoing commitment to delivering innovations that fulfill the unmet needs of our customers, said Joe Gordon, U.S. president, Bausch + Lomb. OVDs play a critical role in cataract surgery as well as many other ophthalmic surgeries. ClearVisc™ offers significant advantages that can help surge